IFRA iShares U.S. Infrastructure ETF

Expense Ratio
0.3%
Dividend
1.69%
Previous close
$57.65
Est. 12 months change
+8.81%
Projected Price
$62.73

Profitability Metrics

Return on Equity (ROE)
16.88%
Return on Assets (ROA)
5.25%
Return on Invested Capital (ROIC)
9.57%
Weighted Average Cost of Capital (WACC)
8.16%
ROIC - WACC
1.41%
Updated : 2026-04-03 17:03 ET

Valuation Metrics

P/E Ratio
24.88
Forward P/E
20.81
PEG Ratio
2.25
Debt Current Ratio
1.29

Growth & Cash Flow

Gross Margin
38.78%
Operating Margin
21.55%
FCF Margin
10.44%
TTM Revenue Growth
11.73%
Projected 12M EPS Growth
19.60%

Price Change

Price % from 50 SMA
-0.86%
Price % from 200 SMA
7.50%
6 Months
9.52%
1 Year
25.68%
2 Years
34.38%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
CAT4.17%
NEE4.10%
UNP3.84%
PWR3.47%
CSX3.14%
SO2.93%
CRH2.89%
CEG2.78%
DUK2.77%
NSC2.71%

ETF Analysis

Fund Overview

iShares U.S. Infrastructure ETF (IFRA) currently reports 161 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is CAT (4.17%), NEE (4.10%), UNP (3.84%), with CAT as the largest single weight at 4.17%. Together, the top three holdings account for 12.11%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 9.57%, WACC is 8.16%, and the economic spread is 1.41%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 16.88% and ROA at 5.25%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

On a multiple basis, the portfolio trades at trailing P/E of 24.88, forward P/E of 20.81, PEG of 2.25. Forward P/E is broadly in line with trailing, suggesting analysts are not projecting a material change in profitability over the coming year. At this PEG level, valuation is defensible given the growth outlook, though there is limited margin of safety against estimate disappointments. The portfolio carries an aggregate current ratio of 1.29, pointing to constrained near-term balance sheet coverage. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 38.78%, operating margin at 21.55%, and free cash flow margin at 10.44%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 8.90%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 11.73% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 19.6% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.